✦ LIBER ✦

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer

✍ Scribed by Masahide Fukudo, Yasuaki Ikemi, Yosuke Togashi…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cerebrospinal fluid concentration of gef

✍ Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 301 KB

Plasma and Pleural Fluid Pharmacokinetic

✍ Katsuhiro Masago; Yosuke Togashi; Masahide Fukudo; Tomohiro Terada; Kaoru Irisa; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 286 KB

Comparison of adverse events and efficac

✍ Tsukasa Yoshida, Kazuhiko Yamada, Koichi Azuma, Akihiko Kawahara, Hideyuki Abe, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 225 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

P-629 A phase I study of erlotinib (Tarc

✍ Atsushi, Horiike; Yamada, Yasuhide; Yamamoto, Noboru; Shimoyama, Tatsu; Murakami 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Phase I/II Pharmacokinetic and Pharmacog

✍ Yamamoto, N; Takahashi, T; Kunikane, H; Masuda, N; Eguchi, K; Shibuya, M; Takeda 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB